Global Premature Ejaculation Treatment Market 2016-2020


#775799

57pages

Technavio

$ 2500

In Stock

About Premature Ejaculation

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient's relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

Technavios analysts forecast the global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report Global Premature Ejaculation Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Absorption Pharmaceuticals
Allergan
Innovus Pharmaceuticals
Plethora

Other prominent vendors
Aytu BioScience
Bayer
Dong-A Pharmaceutical
Eli Lilly
Emcure
Futura Medical
GlaxoSmithKline
NeuroHealing Pharmaceuticals
Pfizer

Market driver
Rise in number of erectile dysfunction cases
For a full, detailed list, view our report

Market challenge
Threat of alternative treatments
For a full, detailed list, view our report

Market trend
Increase in awareness of premature ejaculation
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.





PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Vendor segmentation
Key notes
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Geographical segmentation
Market overview
Premature ejaculation treatment market in Americas
Premature ejaculation treatment market in EMEA
Premature ejaculation treatment market in APAC
PART 07: Market segmentation by route of administration
Market overview
Global premature ejaculation treatment market by oral administration
Global premature ejaculation by topical administration market
PART 08: Market segmentation by mechanism of action
Premature ejaculation treatment market by mechanism of action
PART 09: Market segmentation by off-label drugs
Market segmentation by off-label drugs
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Other prominent vendors
PART 16: Key vendor analysis
Absorption Pharmaceuticals
Allergan
Innovus Pharmaceuticals
Plethora
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Key countries
Exhibit 02: Global premature ejaculation treatment market segmentation: Overview
Exhibit 03: Premature ejaculation prevalence rate for the age group 18-59 by country 2014
Exhibit 04: Premature ejaculation solutions
Exhibit 05: Severity levels of premature ejaculation
Exhibit 06: Clinical diagnosis of premature ejaculation
Exhibit 07: Key product profiles
Exhibit 08: Global premature ejaculation treatment market 2015-2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global premature ejaculation treatment market segmentation by geography 2015-2020
Exhibit 11: Premature ejaculation treatment market in Americas 2015-2020 ($ millions)
Exhibit 12: Types of anxiety affecting adults in US
Exhibit 13: Prevalence rate of premature ejaculation by age group in US
Exhibit 14: Premature ejaculation treatment market in EMEA 2015-2020 ($ millions)
Exhibit 15: Premature ejaculation treatment market in APAC 2015-2020 ($ millions)
Exhibit 16: Number of internet users in APAC countries 2016 (millions)
Exhibit 17: Global premature ejaculation treatment market segmentation by route of administration 2015 and 2020
Exhibit 18: Global premature ejaculation treatment market segmentation by share 2015-2020
Exhibit 19: Global premature ejaculation treatment market by oral administration 2015-2020 ($ billions)
Exhibit 20: Global premature ejaculation treatment market segmentation by topical administration 2015-2020 ($ millions)
Exhibit 21: Market share by mechanism of action 2015-2020
Exhibit 22: Key SSRIs and NSRIs
Exhibit 23: Off-label premature ejaculation drugs market share
Exhibit 24: Impact of drivers
Exhibit 25: Premature ejaculation treatments in pipeline and their side effects
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Internet use by region 2015
Exhibit 28: Absorption: Key takeaways
Exhibit 29: Allergan: Key takeaways
Exhibit 30: Innovus: Key takeaways
Exhibit 31: Plethora: Key takeaways